The widespread availability of diagnostic tools for numerous inherited diseases requires diligent decision-making regarding the risks and benefits, not only for the individual but also at the population level. Should therefore genetic counseling be offered to the entire population at risk for genetic diseases? In our opinion, the goals of public health may only be reached by serving primarily the individual at risk and his/her family. Efforts in public health genetics should be focused on appropriate genetic counseling, especially regarding common diseases with complex genetic components in the near future.

Keywords:
Decision-making, Diagnostic tools, Genetic testing, Public health
1.
Shetty HG, Woods F, Routledge PA: The pharmacology of oral anticoagulants: implications for therapy. J Heart Valve Dis 1993;2:53–62.
2.
Kaminsky LS, Zhang ZY: Human P450 metabolism of warfarin. Pharmacol Ther 1997;73:67–74.
3.
Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE: Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 2002;287:1690–1698.
4.
Tauber AI: Sick autonomy. Perspect Biol Med 2003;46:484–495.
5.
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, et al: A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 1983;306:234–238.
6.
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell 1993;72:971–983.
7.
Meiser B, Dunn S: Psychological effect of genetic testing for Huntington’s disease: an update of the literature. West J Med 2001;174:336–340.
8.
D’Alton ME, DeCherney AH: Prenatal diagnosis. N Engl J Med 1993;328:114–120.
9.
Hagard S, Carter FA: Preventing the birth of infants with Down’s syndrome: a cost-benefit analysis. Br Med J 1976;i:753–756.
10.
Harris RA, Washington AE, Nease RF Jr, Kuppermann M: Cost utility of prenatal diagnosis and the risk-based threshold. Lancet 2004;363:276–282.
11.
Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA, Wilson RD, Mohide P, Hershey D, Krantz D, Zachary J, Snijders R, Greene N, Sabbagha R, MacGregor S, Hill L, Gagnon A, Hallahan T, Jackson L: First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405–1413.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.